Takeda’s High-Dose TYK2 Data Could Set It Apart In Psoriasis

 
• By Jessica Merrill
  
gold medal
Takeda thinks its TYK2 inhibitor could be best in class • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category